Onconetix (J4T) Financial Statements
Onconetix Financial Overview
Onconetix's market cap is currently $2.95M. The company's EPS TTM is $-8.74; its P/E ratio is -0.06; Onconetix has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 815.37K | $ 2.52M | $ 58.47K | $ 0.00 | $ 0.00 |
| Gross Profit | $ 632.91K | $ 1.06M | $ -1.13M | $ -6.75K | $ -4.89K |
| Operating Income | $ -6.34M | $ -56.49M | $ -36.03M | $ -13.48M | $ -3.42M |
| EBITDA | $ -13.27M | $ -57.60M | $ -36.71M | $ -13.41M | $ -3.41M |
| Net Income | $ -14.03M | $ -58.69M | $ -37.41M | $ -13.42M | $ -3.42M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.22M | $ 646.50K | $ 4.55M | $ 25.75M | $ 1.93M |
| Total Assets | $ 24.93M | $ 28.18M | $ 87.52M | $ 26.31M | $ 3.08M |
| Total Debt | $ 48.77K | $ 9.45M | $ 9.89M | $ 0.00 | $ 0.00 |
| Net Debt | $ -5.17M | $ 8.80M | $ 5.33M | $ -25.75M | $ -1.93M |
| Total Liabilities | $ 9.16M | $ 18.57M | $ 86.11M | $ 3.92M | $ 1.64M |
| Stockholders' Equity | $ 15.76M | $ 9.61M | $ -5.60M | $ 22.39M | $ 1.45M |
| Cash Flow | |||||
| Free Cash Flow | $ -9.68M | $ -10.52M | $ -13.64M | $ -8.68M | $ -2.05M |
| Operating Cash Flow | $ -9.68M | $ -10.50M | $ -13.58M | $ -8.68M | $ -2.04M |
| Investing Cash Flow | $ 0.00 | $ -28.47K | $ -8.65M | $ -32.66K | $ -1.92K |
| Financing Cash Flow | $ 14.45M | $ 6.74M | $ 1.04M | $ 32.53M | $ -334.19K |
Currency in USD